0001104659-21-024417.txt : 20210216 0001104659-21-024417.hdr.sgml : 20210216 20210216172831 ACCESSION NUMBER: 0001104659-21-024417 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210211 FILED AS OF DATE: 20210216 DATE AS OF CHANGE: 20210216 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Kelner Simon CENTRAL INDEX KEY: 0001742917 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38223 FILM NUMBER: 21641104 MAIL ADDRESS: STREET 1: C/O RHYTHM PHARMACEUTICALS, INC., STREET 2: 500 BOYLSTON ST., 11TH FLOOR CITY: BOSTON STATE: MA ZIP: 02116 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: RHYTHM PHARMACEUTICALS, INC. CENTRAL INDEX KEY: 0001649904 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 462159271 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 222 BERKELEY STREET STREET 2: 12TH FLOOR CITY: BOSTON STATE: MA ZIP: 02116 BUSINESS PHONE: 857-264-4280 MAIL ADDRESS: STREET 1: 222 BERKELEY STREET STREET 2: 12TH FLOOR CITY: BOSTON STATE: MA ZIP: 02116 FORMER COMPANY: FORMER CONFORMED NAME: RHYTHM METABOLIC, INC. DATE OF NAME CHANGE: 20150803 4 1 tm216849-5_4seq1.xml OWNERSHIP DOCUMENT X0306 4 2021-02-11 0 0001649904 RHYTHM PHARMACEUTICALS, INC. RYTM 0001742917 Kelner Simon 222 BERKELEY STREET, 12TH FLOOR BOSTON MA 02116 0 1 0 0 Chief Human Resources Officer Restricted Stock Units 2021-02-11 4 A 0 6250 0 A Common Stock 6250 6250 D Stock Option (Right to Buy) 30.66 2021-02-11 4 A 0 37500 0 A 2031-02-10 Common Stock 37500 37500 D Each restricted stock unit represents a contingent right to receive one share of Issuer common stock. The restricted stock units vest as to 25% of the total shares on each of February 11, 2022, February 11, 2023, February 11, 2024 and February 11, 2025. The restricted stock units have no expiration date The stock options were granted on February 11, 2021. The options vest and become exercisable in 16 substantially equal installments upon the Reporting Person's completion of each three full months of successive service to the Issuer following the grant date. /s/ Hunter Smith, attorney-in-fact for Simon Kelner 2021-02-16